Skip to main content
Premium Trial:

Request an Annual Quote

Myriad Genetics Earns US Patent for 47 BRCA1 Gene Mutations

Premium

SALT LAKE CITY--Myriad Genetics here has received a patent for 47 different BRCA1 gene mutations that increase the risk of breast and ovarian cancer. The company also received a notice of allowance from the US Patent and Trademark Office for four additional BRCA1 patent applications, including use of the gene or its protein as a breast cancer diagnostic.

Myriad said it will now use its proprietary functional genomic tools, including its ProNet database, to try to uncover the gene's biological role in the disease process.

In related news, the same day it won the patent--December 2--Myriad filed a lawsuit against OncorMed for patent infringement on the BRCA1 gene in the US District Court of Utah. OncorMed, based in Gaithersburg, Md., also has a patent on the BRCA1 gene and said it intends to fight the lawsuit. "Every major gene can be expected to be associated with multiple patents and BRCA1 is no exception," the company stated.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.